Status:
COMPLETED
Holter of Movement in Patients with Multiple Sclerosis in Controlled Environment.
Lead Sponsor:
Laurent Servais
Collaborating Sponsors:
SYSNAV
Centre Hospitalier Régional de la Citadelle
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
ActiSEP is a multicentric academic study. Ambulant patients with multiple sclerosis may be included on a voluntary basis. We plan to include a group of approximately 20 patients with MS. This study i...
Eligibility Criteria
Inclusion
- Confirmed MS diagnosis,
- Over 18 years old,
- Ambulant patients,
- Signed informed consent,
- No clinical and / or radiological relapse within 3 months.
Exclusion
- Patients with excessive cognitive disorders, limiting the understanding of task or with apparent communication difficulties hindering data collection.
- Any other previous or present pathology having an impact on motor function.
- Recent surgery or trauma (less than 6 months) in the upper or lower limbs
Key Trial Info
Start Date :
February 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04888689
Start Date
February 4 2021
End Date
September 30 2021
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Régional de la Citadelle
Liège, Liège, Belgium, 4000